Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,603 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Prevention of dialysis-related amyloidosis].
Yamamoto S, Gejyo F, Kazama JJ. Yamamoto S, et al. Nihon Rinsho. 2004 Jun;62 Suppl 6:353-6. Nihon Rinsho. 2004. PMID: 15250323 Review. Japanese. No abstract available.
Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.
Oyama Y, Kazama JJ, Omori K, Higuchi N, Kameda S, Yamamoto S, Ito Y, Maruyama H, Narita I, Gejyo F. Oyama Y, et al. Among authors: yamamoto s. Clin Exp Nephrol. 2005 Jun;9(2):142-7. doi: 10.1007/s10157-005-0342-2. Clin Exp Nephrol. 2005. PMID: 15980949 Clinical Trial.
Abeta-2M-amyloidosis and related bone diseases.
Kazama JJ, Yamamoto S, Takahashi N, Ito Y, Maruyama H, Narita I, Gejyo F. Kazama JJ, et al. Among authors: yamamoto s. J Bone Miner Metab. 2006;24(2):182-4. doi: 10.1007/s00774-005-0669-5. J Bone Miner Metab. 2006. PMID: 16502130 Review.
10,603 results
You have reached the last available page of results. Please see the User Guide for more information.